Tag

Dr. Reddy's Laboratories Ltd.

2 articles

Corona Remedies Acquires Wokadine® from Dr. Reddy's

Corona Remedies acquires Wokadine® brand from Dr. Reddy's Laboratories, marking its fifth inorganic acquisition, effective March 30, 2026. Wokadine® is ranked #2 in India's INR 648 Cr Povidone Iodine

Dr. Reddy's ESOP Share Allotment 3,675 Shares

Dr. Reddy's Laboratories allotted 3,675 equity shares of Re.1 each on March 26, 2026, under its ADR Stock Options Scheme, 2007. Shares were issued at two exercise prices: 575 shares at Re.1 each and 3